CN103228725A - Novel polymeric thickening agent free of acrylamide fragments, method for the preparation thereof, and composition containing same - Google Patents

Novel polymeric thickening agent free of acrylamide fragments, method for the preparation thereof, and composition containing same Download PDF

Info

Publication number
CN103228725A
CN103228725A CN2011800575323A CN201180057532A CN103228725A CN 103228725 A CN103228725 A CN 103228725A CN 2011800575323 A CN2011800575323 A CN 2011800575323A CN 201180057532 A CN201180057532 A CN 201180057532A CN 103228725 A CN103228725 A CN 103228725A
Authority
CN
China
Prior art keywords
composition
acid
formula
inverse latex
defined above
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2011800575323A
Other languages
Chinese (zh)
Other versions
CN103228725B (en
Inventor
O·布朗
P·马洛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PROD POUR LES IND CHIMIQUES SE
Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA
Original Assignee
PROD POUR LES IND CHIMIQUES SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PROD POUR LES IND CHIMIQUES SE filed Critical PROD POUR LES IND CHIMIQUES SE
Publication of CN103228725A publication Critical patent/CN103228725A/en
Application granted granted Critical
Publication of CN103228725B publication Critical patent/CN103228725B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L33/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • C08L33/02—Homopolymers or copolymers of acids; Metal or ammonium salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/064—Water-in-oil emulsions, e.g. Water-in-silicone emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8164—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical, and containing at least one other carboxyl radical in the molecule, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers, e.g. poly (methyl vinyl ether-co-maleic anhydride)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2/00—Processes of polymerisation
    • C08F2/32—Polymerisation in water-in-oil emulsions
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F20/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L33/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • C08L33/04—Homopolymers or copolymers of esters
    • C08L33/14—Homopolymers or copolymers of esters of esters containing halogen, nitrogen, sulfur, or oxygen atoms in addition to the carboxy oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/08—Preparations containing skin colorants, e.g. pigments for cheeks, e.g. rouge
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/14—Preparations for removing make-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/002—Aftershave preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/002—Preparations for repairing the hair, e.g. hair cure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/04—Acids; Metal salts or ammonium salts thereof
    • C08F220/06—Acrylic acid; Methacrylic acid; Metal salts or ammonium salts thereof

Abstract

The invention relates to a composition including an oil phase, an aqueous phase, at least one water-in-oil emulsifying system in the form of a positive latex, characterized in that the composition includes a straight, branched, or cross-linked anionic polyelectrolyte, including: a) a non-zero molar proportion of monomer units from acrylic acid in free or partially salified form; and b) a non-zero molar proportion of monomer units from the acid of formula (I): CH2=CH-C(=O)-O-[CH2-CH2-C(=O)-O]n-H (I), where n is a number greater than or equal to (1) and less than or equal to (5), in free or partially salified form. The invention also relates to a method for preparing the same, to a polymer powder, and to the use thereof as a thickening agent for cosmetic or pharmaceutical compositions.

Description

The segmental novel polymeric thickening material of no acrylamide, its preparation method and contain the composition of this polymeric viscosifier
Theme of the present invention be novel polymerization anionic thickener, its preparation method with and as the purposes of thickening material and/or emulsifying agent.
The thickening of water is undertaken by mixing all types of hydrophilic polymers (no matter they are synthetic or natural origin) therein usually.
In the polymkeric substance of natural origin, quite be extensive use of xanthan gum or guar gum.But they have the traditional drawback of natural product, i.e. quality and price volalility.
In hydrophilic synthetic thickening agent, the most widely used is powder or from the polymkeric substance of reversible inverse latex form.With regard to chemical structure, they are the acrylate homopolymer of the form of free or partially salinated particularly; The homopolymer of free form is synthetic by precipitation polymerization usually, and is powder type; For the homopolymer of the form of partially salinated, they prepare by precipitation polymerization or by inverse emulsion polymerization usually.For example, disclose from reversible inverse latex in publication number is the european patent application of EP1010708A1, wherein acrylate homopolymer is with the form salinization of ammonium salt or monoethanolamine salt.But the thickening power of the polymkeric substance of this first kind is not exclusively satisfactory, because the existence of nitrogenous base, their bad smell has limited their application in cosmetic industry.Publication number is that the european patent application of EP017025A1 discloses as the vinylformic acid of photographic film layer and the multipolymer of acrylic acid dimer.Publication number is that the German patent application of DE102009014877A1 discloses the 2-acrylamido-1-methyl propane sulfonic acid that is used in the cosmetic industry and the multipolymer of propyloic acrylic ester.
The inventor attempts to develop and has than the good thickening power of the acrylate copolymer of prior art and do not have the thickening polymer of the shortcoming of bad smell aspect.
According to first aspect, a composition that theme is the inverse latex form of the present invention, it comprises oil phase, water and at least a invert emulsion system, it is characterized in that it comprises straight chain, side chain or crosslinked anionoid polymerization ionogen, and this anionoid polymerization ionogen comprises:
A) monomeric unit that produces of the vinylformic acid by the form of free or partially salinated of non-zero molar ratio and
B) monomeric unit that produces of the mixture by the acid of the acid of formula (I) or formula (I) of non-zero molar ratio
CH 2=CH-C(=O)-O-[CH 2-CH 2-C(=O)-O] n-H (I)
Wherein n represents more than or equal to 1 and is less than or equal to 5 number, and described acid is the form of free or partially salinated.
Term " inverse latex " is meant the water-in-oil emulsion of at least a polymkeric substance.
Term " side chain polyelectrolyte " thereby be meant when the non-straight chain polyelectrolyte with side chain dissolves in water obtains the state that highly tangles, the very high viscosity of generation under the low rate of change gradient.
Term " crosslinking polymerization ionogen " is meant the non-straight chain polyelectrolyte of three-dimensional network form, but its water insoluble be water-swellable and therefore obtain chemical gel.
In the definition of inverse latex as defined above, term " salinization " is meant that it relates to an alkali metal salt, for example sodium or sylvite.
The polyelectrolyte composition of described inverse latex can comprise a crosslink unit and/or a chain unit.
In composition as defined above, " water-in-oil " (W/O) emulsification system constituted or is made of surfactant mixtures by single tensio-active agent, and condition is that described tensio-active agent or described mixture have the HLB value that enough low being enough to causes water-in-oil emulsion.Can mention for example sorbitan ester, for example SEPPIC company is with Montane TMThe sorbitan oleic acid ester that 80 run after fame sells, SEPPIC company are with Montane TMSorbitan isostearate that 70 run after fame sells or SEPPIC company are with Montane TM83 NOFABLE SO-992 of running after fame and selling.Also can mention the sorbitan ester of some many ethoxylation, for example SEPPIC company is with Montanox TMThe dehydrated sorbitol mono-fatty acid ester of five ethoxylations that 81 run after fame sells or SEPPIC company are with Montanox TMThe sorbitan isostearate of five ethoxylations that 71 run after fame sells.Also can mention by poly-(isobutenyl) succsinic acid or its acid anhydride and between the molecular weight that produces of condensation be 1000 to 3000 polyester, the Hypermer that sells of Uniqema company for example TM2296, or last, and molecular weight is 2500 to 3500 segmented copolymer, for example the Hypermer of Uniqema company sale TMThe Simaline that B246 or SEPPIC company sell TMIE200.
Composition comprises described " water-in-oil " emulsification system of 0.5 weight % to 10 weight % usually as defined above.
For 100 weight %, this inverse latex comprises 1% to 50 weight % water usually.
Above-mentioned oil phase from reversible inverse latex is made by following substances:
-mineral oil or mineral oil mixture, the stable hydrocarbon that it contains paraffinic hydrocarbons, isoparaffin or naphthenic hydrocarbon type has 0.7 to 0.9 density at ambient temperature and is higher than 180 ℃ boiling point, for example the Isopar of Exxon sale TMM or Isopar TML, Exxol TMD100S or meet FDA21CFR172.878 and FR178.3620(a) mineral white oil of regulations, for example Marcol that also sells by Exxon TM52 or Marcol TM82;
-or synthetic oil or synthetic oil mixture, Parleam for example, particularly in France by Ets B.Hossow and Cie company with Parleam-Polysynlane TMRun after fame and sell and at Michel and Irene Ash; Thesaurus of Chemical products, Chemise Publicit é Cos, Ince.1986 I volume, those that quote in the 211st page (ISBN0713136030); Poly decene; With the isohexadecane of label RN=93685-80-4 sign, it is to contain 97%C at least in Chemical Abstracts 16The C of isoparaffin 12, C 16And C 20The mixture of isoparaffin, wherein main component is 2,2,4,4,6,8,8-heptamethylnonane (RN=4390-04-9), it is sold by Bayer company in France; The Permethyl 99A. of selling by Bayer company in France;
-or vegetables oil or vegetable oil mixt, for example in Chemical Abstracts, use the squalane of label RN=111-01-3 sign, it is to contain more than 80 weight %2,6,10,15,19, the hydrocarbon mixture of 23-squalane, or the vegetables oil of ester or triglyceride level type, cocounut oil-octanoate/decylate for example, for example DUB that provides of Dubois company TM810C, or jojoba oil;
-or these various oil in several mixture.
For 100 weight %, composition comprises the oil of 5% to 50 weight % usually as defined above.
According to a particular aspects, as the polyelectrolyte composition of the composition of theme of the present invention comprise the non-zero molar ratio by formula (I 1) the monomeric unit that produces of acid:
CH 2=CH-C(=O)-O-CH 2-CH 2-C(=O)-O-H （I 1）
Formula (I 1) being equivalent to the formula as defined above (I) that the representative of n wherein equals 1 number, described acid is the form of free or partially salinated.
According to another particular aspects, as the polyelectrolyte composition of the composition of theme of the present invention comprise the non-zero molar ratio by formula (I 1) acid and formula (I 2) the monomeric unit that produces of the mixture of acid:
CH 2=CH-C(=O)-O-CH 2-CH 2-C(=O)-O-H （I 1）
Formula (I 1) be equivalent to the formula as defined above (I) that the representative of n wherein equals 1 number,
CH 2=CH-C(=O)-O-CH 2-CH 2-C(=O)-O-CH 2-CH 2-C(=O)-OH （I 2）
Formula (I 2) being equivalent to the formula as defined above (I) that the representative of n wherein equals 2 number, described acid is the form of free or partially salinated, (I 1)/(I 2) mol ratio is greater than 1, and is more special in 1.5.
According to another particular aspects, as the polyelectrolyte composition of the composition of theme of the present invention comprise the non-zero molar ratio by formula (I 1) acid, formula (I 2) acid and formula (I 3) the monomeric unit that produces of the mixture of acid:
CH 2=CH-C(=O)-O-CH 2-CH 2-C(=O)-O-H （I 1）
Formula (I 1) be equivalent to the formula as defined above (I) that the representative of n wherein equals 1 number,
CH 2=CH-C(=O)-O-CH 2-CH 2-C(=O)-O-CH 2-CH 2-C(=O)-OH （I 2）
Formula (I 2) be equivalent to the formula as defined above (I) that the representative of n wherein equals 2 number,
CH 2=CH-C(=O)-O-CH 2-CH 2-C(=O)-O-CH 2-CH 2-C(=O)-O-CH 2-CH 2-C(=O)-OH (I 3)
Formula (I 3) being equivalent to the formula as defined above (I) that the representative of n wherein equals 3 number, described acid is the form of free or partially salinated, (I 1)/(I 2) mol ratio is greater than 1, and is more special in 1.5, and (I 2)/(I 3) mol ratio is greater than 1.5, and is more special in 2.
According to a particular aspects, for 100 moles of %, the anionoid polymerization electrolyte ingredient of inverse latex comprises as defined above:
The monomeric unit that the vinylformic acid by free or partially salinated of-90 moles of % to 99.5 mole of %, more special 95 moles of % to 99 mole of % produces;
The monomeric unit that the carboxylic acid of the formula by free or partially salinated of-0.5 mole of % to 10 mole of %, more special 1 mole of % to 5 mole of % (I) produces.
According to another particular aspects of the present invention, the anionoid polymerization ionogen is crosslinked as defined above.
Under one situation of back, linking agent is selected from diolefin or polyenic compounds especially, the most special two allyloxy acetate or its salt of being selected from, its sodium salt particularly, triallylamine or its salt, Viscoat 295, ethylene glycol dimethacrylate, diethylene glycol diacrylate, diallyl urea or methylene-bis (acrylamide).
According to a particular aspects of the present invention, used linking agent is triallylamine or methylene-bis (acrylamide).
This linking agent uses with the molar ratio of representing with respect to used monomer of 0.005 mole of % to 1 mole of % usually.
According to another particular aspects of the present invention, composition also comprises " oil-in-water " emulsification system as defined above.
Described " oil-in-water (O/W) emulsification system " constituted or is made of surfactant mixture by single tensio-active agent, and condition is that described tensio-active agent or described mixture have the sufficiently high HLB value that is enough to cause water external emulsion.For example can mention:
The sorbitan ester of-ethoxylation, for example SEPPIC company is with Montanox TM80 run after fame sell, by the sorbitan oleic acid ester of the many ethoxylations of 20 moles of ethylene oxide, or SEPPIC company is with Montanox TM20 run after fame sell, by the sorbitan laurate esters of the many ethoxylations of 20 moles of ethylene oxide;
-with Simulsol TMOL50 run after fame sell, by the Viscotrol C of the many ethoxylations of 40 moles of ethylene oxide;
-SEPPIC company is with Simulsol TMThe run after fame ol é od é cylique alcohol of ten ethoxylations of selling of OC710;
-with Simulsol TMThe run after fame dodecanol of seven ethoxylations of selling of P7; Or
-SEPPIC company is with run after fame sorbitan six oleic acid esters of many ethoxylations of selling of Simaline IE400.
When it also comprises " oil-in-water " emulsification system, as defined above composition be comprise usually 1 weight % to 15 weight % described " oil-in-water " emulsification system from reversible inverse latex form.
Composition of the present invention also can contain various additives, for example complexing agent or chain restriction agent.
According to another particular aspects of the present invention, its theme is a composition as defined above, and it comprises the described anionoid polymerization ionogen of 15 weight % to 60 weight %, preferred 25 weight % to 40 weight %.
According to another particular aspects of the present invention, its theme is a composition as defined above, and it comprises more than 60 weight % to 80 weight %, preferably more than the described anionoid polymerization ionogen of 60 weight % to 70 weight %.
The compound that n equals 1 formula (I) is known as 4-oxa--5-oxo-6-heptenoic acid or propenoic acid beta-carboxylic ethyl ester, is the commercially available prod.It identifies with label CAS=24615-84-7.
According to a further aspect in the invention, its theme is the method for compositions that preparation as above-mentioned aspect define in each, comprises the steps:
Step a),In this process, comprising emulsification in the oil phase of lipophilic described monomer and described optional additives at the aqueous solution that will comprise hydrophilic described monomer and described optional additives in the presence of the described invert emulsion system;
Step b),In this process, by introducing radical initiator and coinitiator randomly in the milk sap that forms when step a) finishes, initiated polymerization makes it carry out described composition with acquisition inverse latex form then.
As the process of step b) of the method for definition in, usually by generating bisulfite (HSO 3) the ionic oxidation/reduction is right, cumene hydroperoxide/Sodium Pyrosulfite (Na for example 2S 2O 5) right, or cumene hydroperoxide/thionyl chloride (SOCl 2) right, be less than or equal to initiated polymerization under 10 ℃ the temperature, if desired; be accompanied by photoreactive polymers; for example azo two (isopropyl cyanide), dilauroyl peroxide or Sodium Persulfate proceed to quasi-adiabatic the temperature more than or equal to 50 ℃ then, or are undertaken by controlled temperature.
According to a particular aspects, method also comprises as defined above Step c), in this process, be to add to described oil-in-water emulsion Step b)In the inverse latex that forms during end, to obtain described composition from reversible inverse latex form.
In the process of the step c) of method as defined above, be less than or equal to the interpolation of carrying out described oil-in-water emulsion system under 50 ℃ the temperature usually.
According to a particular aspects, also comprise as the method that defines Step b 1 , in this process, if suitably implementing Step c)Before, will available from Step b)Inverse latex concentrate to obtain the described composition of spissated inverse latex form.
According to a particular aspects, method also comprises as defined above Step c 1 , in this process, will available from Step c)Concentrate to obtain spissated described composition from reversible inverse latex from reversible inverse latex form.
At the step b of method as defined above 1Or step c 1Process in, usually carry out concentrating of medium until reaching the anionoid polymerization ionogen as the desirable content in the composition of theme of the present invention by distillation.
According to a particular aspects, method also comprises as defined above Step d), in this process, will available from Step b)Inverse latex, available from Step b1)Spissated inverse latex, available from Step C)From reversible inverse latex or available from Step c1)Spissated from reversible inverse latex spraying drying, to form the electrolytical powder of described anionoid polymerization.
Theme of the present invention also has straight chain or the crosslinked electrolytical powder of anionoid polymerization, it is characterized in that it is by method acquisition as defined above.
As the anionoid polymerization ionogen of theme of the present invention and comprise its inverse latex and be advantageously used for thickening material and/or emulsifying agent/stablizer in makeup or the pharmaceutical composition from reversible inverse latex.
Therefore, according on the other hand, theme of the present invention is the composition or the purposes of powder as defined above as defined above, as thickening material and/or the emulsifying agent in makeup or the pharmaceutical composition.
As the powder of theme of the present invention or randomly can be formulated in makeup or the pharmaceutical preparation (for example mousse, gel, washing lotion, spraying, shampoo, hair conditioner, handguard breast and health breast and sunscreen), be more typically in the care products from the composition of reversible inverse latex form.
Under the situation of hair treatment or maintenance, the form of the normally shampoo of this makeup or pharmaceutical composition, emulsion, microemulsion, special under the situation of hair conditioner, be transpirable emulsion form.
According to last aspect, theme of the present invention is makeup or pharmaceutical composition, it is characterized in that its contain the composition as defined above of significant quantity or as defined above powder as emulsifying agent and/or thickening material.
Term " significant quantity " is meant the part by weight of about 1 weight % to the composition as defined above of about 10 weight % and the about 0.2 weight % powder as defined above to about 5%.
The present invention of following embodiment illustration, but do not limit the present invention.
Embodiment A: with triallylamine crosslinked with acrylic acid homopolymer of sodium-salt form partially salinated From reversible inverse latex (prior art)
Preparation from reversible inverse latex
-by mixing following material, the preparation oil phase:
261 gram Marcol TM52,
15.5 gram Montane TM80VG and
3.5 gram Montanox TM81:3.5g.
-by introducing following material, the preparation water:
203 gram glacial acrylic acids,
188 grams contain the aqueous solution of 48 weight % sodium hydroxide,
0.45 gram Versenex TM80,
0.77 the gram triallylamine makes weight reach 653 grams with deionized water then.
-water is introduced in the oil phase, and use Ultra Turrax TMDevice carries out emulsification.
-in this system of stirring and after, it is cooled to 10 ℃ with the nitrogen bubbling, and to wherein adding 10 cubic centimetres at Marcol TMThe solution that contains 0.268 weight % cumene hydroperoxide in 52 adds the aqueous solution that 20 grams contain 0.54 weight % Sodium Pyrosulfite then gradually.
-make the temperature in the reaction medium rise to 80 ℃, reaction was carried out 1 hour.With 30 gram Montanox TM80 introduce in the final inverse latex of gained.
The viscosity analysis of the reversible inverse latex that derives from
3 weight % are from the viscosity of the water dispersion of reversible inverse latex: 55800mPas(Brookfield TMRVT, axle 6, speed: 5 rev/mins).
Contain 0.1 weight % sodium-chlor and 3 weight % viscosity: 3200mPas(Brookfield from the water dispersion of reversible inverse latex TMRVT, 3,5 rev/mins of axles).
Embodiment 1: with the crosslinked vinylformic acid/propenoic acid beta with the sodium-salt form partially salinated-carboxylic of triallylamine The multipolymer of ethyl ester is at Marcol TM In 52 from reversible inverse latex(composition 1)
Preparation from reversible inverse latex
-by mixing following material, the preparation oil phase:
261 gram Marcol TM52,
15.5 gram Montane TM80VG and
3.5 gram Montanox TM81:3.5g.
-by introducing following material, the preparation water:
186 gram glacial acrylic acids,
17.3 the propenoic acid beta-carboxylic ethyl ester of gram, Bimax company is with Beta-C TMThe sale of running after fame,
188 grams contain the aqueous solution of 48 weight % sodium hydroxide,
0.45 gram Versenex TM80,
0.77 the gram triallylamine makes weight reach 653 grams with deionized water then.
-water is introduced in the oil phase, and use Ultra Turrax TMDevice carries out emulsification.
-in this system of stirring and after, it is cooled to 10 ℃ with the nitrogen bubbling, and to wherein adding 10 cubic centimetres at Marcol TMThe solution that contains 0.268 weight % cumene hydroperoxide in 52 adds the aqueous solution that 20 grams contain 0.54 weight % Sodium Pyrosulfite then gradually.
-make the temperature in the reaction medium rise to 80 ℃, reaction was carried out 1 hour.With 30 gram Montanox TM80 introduce in the final inverse latex of gained.
The viscosity analysis of the reversible inverse latex that derives from
3 weight % are from the viscosity of the water dispersion of reversible inverse latex: 80400mPas(Brookfield TMRVT, axle 6, speed: 5 rev/mins).
Contain 0.1 weight % sodium-chlor and 3 weight % viscosity: 5600mPas(Brookfield from the water dispersion of reversible inverse latex TMRVT, 3,5 rev/mins of axles).
This analysis can confirm the thickening power of more strengthening from reversible inverse latex than embodiment A, and this is owing to there is the monomeric unit that is produced by propenoic acid beta-carboxylic ethyl ester.Also note that the slight improvement of salts contg.
Embodiment 2: with the crosslinked vinylformic acid/propenoic acid beta with the sodium-salt form partially salinated-carboxylic of triallylamine The multipolymer of ethyl ester in squalane from reversible inverse latex(composition 2)
This method is carried out as in Example 1, with Marcol TM52 change Squalane into TMVG.Obtain expection from reversible inverse latex.
Embodiment 3: with the crosslinked vinylformic acid/propenoic acid beta with the sodium-salt form partially salinated-carboxylic of triallylamine The multipolymer of ethyl ester is at Iso p Ar TM Among the M from reversible inverse latex(composition 3)
This method is carried out as in Example 1, with Marcol TM52 change Isopar into TMM.Obtain expection from reversible inverse latex.
Embodiment 4: with the crosslinked vinylformic acid/propenoic acid beta with the sodium-salt form partially salinated-carboxylic of triallylamine The powder of the multipolymer of ethyl ester
By distill concentrate obtain among the last embodiment from reversible inverse latex, spraying drying then.
Example of formulations
Embodiment 5: protective skin cream
Figure BDA00003272538400101
Figure BDA00003272538400111
Embodiment 6: protective skin cream
Figure BDA00003272538400112
Embodiment 7: must back cream
Prescription
Program: B is added among the A.
Embodiment 8: bright health breast
FORMULA
Figure BDA00003272538400121
Program: C is added among the B, under 70 ℃ in A emulsification B, add down D and add E down at 60 ℃ then at 30 ℃.
Embodiment 9: the health breast
Prescription
Figure BDA00003272538400122
Figure BDA00003272538400131
Program: under about 75 ℃ in A emulsification B; Add C down at about 60 ℃, add D down at about 30 ℃ then.
Embodiment 10:O/W Cream
Prescription
Figure BDA00003272538400132
Program: at about 75 ℃ B introduced among the A; Add C down at about 60 ℃, add D down at about 45 ℃ then.
Embodiment 11: the sun protection gel of non-greasy
Prescription
Figure BDA00003272538400133
Figure BDA00003272538400141
Program: B is introduced among the A; Add C, D, E then then.
Embodiment 12: sunscreen
Prescription
Figure BDA00003272538400142
Program: under 75 ℃ in A emulsification B, add down C at about 60 ℃ then, add D down at about 30 ℃ then, if necessary, regulate pH.
Embodiment 13: massage gel
Prescription
Figure BDA00003272538400153
Program: B is added among the A; Then C is added in this mixture, then D.
Embodiment 14: massage gel
Prescription
Program: preparation A; Add B, C, D then then.
Embodiment 15: glossy gel
Prescription
Figure BDA00003272538400152
Program: preparation A; Add B, C, D then then.
Embodiment 16: the health breast
Prescription
Program: at about 75 ℃ of following fusion A.Under 75 ℃ in A emulsification B, add down C, D then at about 60 ℃ then.
Embodiment 17: the makeup removing breast that contains sweet almond oil
Prescription
Figure BDA00003272538400162
Embodiment 18: oiliness skin moisturizer
Prescription
Figure BDA00003272538400163
Figure BDA00003272538400171
Embodiment 19: alcohol-free releiving must back cream
Prescription
Figure BDA00003272538400172
Embodiment 20: the breast frost that contains AHA that responsive skin is used
Prescription
Figure BDA00003272538400173
Figure BDA00003272538400181
Embodiment 21: the care products of releiving after the solarization
Prescription
Figure BDA00003272538400182
Embodiment 22: the makeup removing breast
Prescription
Figure BDA00003272538400183
Embodiment 23: the health breast
Prescription
Figure BDA00003272538400191
Embodiment 24: the emulsion under alkaline pH
Figure BDA00003272538400192
Embodiment 25: foundation emulsion
Prescription
Figure BDA00003272538400193
Embodiment 26: sunscreen
Prescription
Figure BDA00003272538400201
Embodiment 27: the eye gel
Prescription
Figure BDA00003272538400202
Embodiment 28: disposable care composition
Prescription
Figure BDA00003272538400203
Embodiment 29: slim gel
Figure BDA00003272538400211
Embodiment 30: alcohol-free releiving must back cream
Prescription
Embodiment 31: clearly must the back gel
Prescription
Figure BDA00003272538400221
Embodiment 32: oiliness skin nursing product
Prescription
Figure BDA00003272538400222
Embodiment 33: the breast frost that contains AHA
Prescription
Figure BDA00003272538400223
Embodiment 34: the black product of U.S. of the non-greasy of face and health
Prescription
Figure BDA00003272538400231
Embodiment 35: contain
Figure BDA00003272538400234
The sunscreen of oil
Prescription
Embodiment 36: facial sun-proof nursing product
Prescription
Figure BDA00003272538400233
Figure BDA00003272538400241
Embodiment 37: the U.S. black emulsion of no Exposure to Sunlight
Prescription
Figure BDA00003272538400242
Embodiment 38: glossy gel
Figure BDA00003272538400243
Embodiment 39: slim gel
Figure BDA00003272538400244
Figure BDA00003272538400251
Embodiment 40: the makeup removing breast
Embodiment 41: sunscreen
Embodiment 42: the mixed skin nursing gel
Figure BDA00003272538400262
Embodiment 43: fragrance health film
Figure BDA00003272538400263
Embodiment 44: the breast frost that contains VITAMIN
Figure BDA00003272538400264
Figure BDA00003272538400271
Embodiment 45: the resistance to compression hair products
Prescription
Phase A
Water: qs100%
Xanthan gum: 0.50%
Phase B
Sepicap TM MP: 3.00％
Phase C
Composition 1:4.00%
Phase D
Figure BDA00003272538400272
Program: with deflocculator xanthan gum is dispersed in the water.Add Sepicap then TMMP, composition 1 then; It is disperseed, add the composition of phase D then.
Embodiment 46: the white film of regeneration breast of pressurized and embrittlement hair
Prescription
Phase A
Figure BDA00003272538400273
Figure BDA00003272538400281
Phase B
Water: q.s.100%
Phase C
Sepicap TM MP: 3.00％
Sepicide TM HB: 0.30％
Sepicide TM CI: 0.20％
Program: at 75 ℃ of following fusion phase A.Phase B is heated to 75 ℃.Emulsification A in B.Under about 40 ℃, introduce the composition of phase C.
Embodiment 47: purify facial gel
Prescription
Phase A
Montaline TM C 40: 7.00％
Pearlescent base 2078: 5.00％
Composition 1:2.00%
Phase B
Water: q.s.100%
Embodiment 48: painted shampoo
Prescription
Phase A
Figure BDA00003272538400282
Phase B
Tinting material qs
Water q.s.100%
Embodiment 49: shampoo
Figure BDA00003272538400292
Embodiment 50: the shampoo of protecting and releive
Figure BDA00003272538400293
Embodiment 51: disposable protective agent; The resistance to compression hair products
Figure BDA00003272538400301
Montanov TM68 (cetearyl glucoside) are the self-emulsifying compositions described in WO92/06778, are sold by SEPPIC company.
Montanov TM82 are based on the emulsifying agent of the pure and mild cocounut oil acyl of cetearyl alcohol glucoside.
Montanov TMThe 202nd, the APG/ Fatty Alcohol(C12-C14 and C12-C18) composition described in WO98/47610 is sold by SEPPIC company.
Micropearl TMLM is the mixture of the squalane of SEPPIC company sale, poly-(methyl methacrylate) and menthol.
Micropearl TMM100 be Matsumo company sell have a very ultrafine powder of softish sense of touch and photoextinction.
Micropearl TMSQL is the mixture that contains the particulate of the squalane that discharges under massage effect; It is sold by Matsumo company.
Sepicide TMHB is the mixture of phenoxyethyl alcohol, methyl p-hydroxybenzoate, ethyl p-hydroxybenzoate, propylparaben and butyl p-hydroxybenzoate, and it is the sanitas that SEPPIC company sells.
Sepicide TMCI, the imidazolidine urea is the sanitas that SEPPIC company sells.
Pemulen TMTR is the acrylate copolymer that Goodrich sells.
Simulsol TMThe 165th, the self-emulsifying stearin that SEPPIC company sells.
Lanol TM14M and Lanol TMS is the consistency factor that SEPPIC company sells.
Lanol TM84D is the oxysuccinic acid dioctyl ester that SEPPIC company sells.
Lanol TMThe 99th, the isononyl isononanoate that SEPPIC company sells.
Lanol TM37T is the triheptin that SEPPIC company sells.
Lanol TMP is the additive with stabilization that SEPPIC company sells.
Lanol TMThe 1688th, the emollient ester that SEPPIC company sells with the effect of deoiling.
Lanol TMThe 2681st, lauric alcohol octanoate/decylate mixture that SEPPIC company sells.
Monteine TMCA is the wetting Agent for Printing Inks that SEPPIC company sells.
Schercemol TMOP is the emollient ester with the effect of deoiling.
Parsol TMMCX is the p-methoxycinnamic acid monooctyl ester that Givaudan company sells.
Sepiperl TMN is the pearling agent that SEPPIC company sells, based on the mixture of alkyl polyglucoside, for example those described in the WO95/13863.
Solagum TML is the carrageenin that SEPPIC company sells.
Marcol TMThe 82nd, the whiteruss that Exxon company sells.
Parsol TMNOX is the sun-screening agent that Givaudan company sells.
Eusolex TMThe 4360th, the sun-screening agent that Merck company sells.
Dow Corning TM245Fluid is the cyclomethicone that Dow Corning company sells.
Lipacide TMPVB is the acidylate hydrolyzed wheat protein product that SEPPIC company sells.
Sepicontrol TMA5 is the mixture of decoyl glycine, sarkosine and the Cortex Cinnamomi extract of the sale of SEPPIC company, for example those described in the International Patent Application PCT/FR98/01313 that submitted on June 23rd, 1998.
Capigel TMThe 98th, the acrylic copolymer that SEPPIC company sells.
Commodity used among the embodiment are defined as follows:
Montaline TM(the cocamoniumcarbamoyl chloride) that C40:SEPPIC sells.
Sepiperl TM(the cocoyl glucoside/cocoyl alcohol) that N:SEPPIC sells.
Amonyl TM(Quaternium82) that DM:SEPPIC sells.
Sepicap TM(the cocoyl amino acid sodium/dimethicone copolyol panthenol base potassiumphosphate) that MP:SEPPIC sells
Simulsol TMThe 1293rd, the ethoxylation index that SEPPIC company sells equals 40 the hydrogenation and the Viscotrol C of ethoxylation.
Ketrol TMT is the xanthan gum that Kelco company sells.
DC1501 is the D5 of Dow Chemical company sale and the mixture of dimethiconol.

Claims (14)

1. the composition of inverse latex form, it comprises oil phase, water and at least a invert emulsion system, it is characterized in that it comprises straight chain, side chain or crosslinked anionoid polymerization ionogen, and described anionoid polymerization ionogen comprises:
A) monomeric unit that produces of the vinylformic acid by the form of free or partially salinated of non-zero molar ratio and
B) the non-zero molar ratio by the acid of formula (I) or the monomeric unit that produces by the mixture of the acid of formula (I)
CH 2=CH-C(=O)-O-[CH 2-CH 2-C(=O)-O] n-H (I)
Wherein n represents more than or equal to 1 and is less than or equal to 5 number, and described acid is the form of free or partially salinated.
2. the composition described in claim 1, wherein for 100 moles of %, described anionoid polymerization ionogen comprises:
The monomeric unit that the vinylformic acid by free or partially salinated of-90 moles of % to 99.5 mole of %, more special 95 moles of % to 99 mole of % produces;
The monomeric unit that the carboxylic acid of the formula by free or partially salinated of-0.5 mole of % to 10 mole of %, more special 1 mole of % to 5 mole of % (I) produces.
3. the composition described in claim 1 or 2, wherein said anionoid polymerization ionogen comprise the non-zero molar ratio by formula (I 1) acid and formula (I 2) the monomeric unit that produces of the mixture of acid:
CH 2=CH-C(=O)-O-CH 2-CH 2-C(=O)-O-H (I 1)
Its Chinese style (I 1) be equivalent to the formula as defined above (I) that the representative of n wherein equals 1 number,
CH 2=CH-C(=O)-O-CH 2-CH 2-C(=O)-O-CH 2-CH 2-C(=O)-OH (I 2)
Its Chinese style (I 2) be equivalent to the representative of n wherein and equal 2 number formula (I) as defined above,
Described acid is the form of free or partially salinated, (I 1)/(I 2) mol ratio is greater than 1, and is more special in 1.5.
4. the composition described in claim 2, wherein said anionoid polymerization ionogen comprise the non-zero molar ratio by formula (I 1) acid, formula (I 2) acid and formula (I 3) the monomeric unit that produces of the mixture of acid:
CH 2=CH-C(=O)-O-CH 2-CH 2-C(=O)-O-H (I 1)
Its Chinese style (I 1) be equivalent to the formula as defined above (I) that the representative of n wherein equals 1 number,
CH 2=CH-C(=O)-O-CH 2-CH 2-C(=O)-O-CH 2-CH 2-C(=O)-OH (I 2)
Its Chinese style (I 2) be equivalent to the formula as defined above (I) that the representative of n wherein equals 2 number,
CH 2=CH-C(=O)-O-CH 2-CH 2-C(=O)-O-CH 2-CH 2-C(=O)-O-CH 2-CH 2-C(=O)-OH (I 3)
Its Chinese style (I 3) be equivalent to the formula as defined above (I) that the representative of n wherein equals 3 number,
Described acid is the form of free or partially salinated, (I 1)/(I 2) mol ratio is greater than 1, and is more special in 1.5, and (I 2)/(I 3) mol ratio is greater than 1.5, and is more special in 2.
5. as the composition of claim 1 to 4 described in each, wherein the anionoid polymerization ionogen is crosslinked as defined above.
6. as the composition of claim 1 to 5 described in each, it comprises the described anionoid polymerization ionogen of 15 weight % to 80 weight %.
7. as the composition of claim 1 to 6 described in each, it also comprises " oil-in-water " emulsification system.
8. preparation comprises the steps: as the method for compositions of claim 1 to 7 described in each
Step a), in this process, comprising emulsification in the oil phase of lipophilic described monomer and described optional additives at the aqueous solution that will comprise hydrophilic described monomer and described optional additives in the presence of the described invert emulsion system;
Step b), in this process, by introducing radical initiator and coinitiator randomly in the milk sap that forms when step a) finishes, initiated polymerization makes it carry out described composition with acquisition inverse latex form then.
9. the method described in claim 8, it also comprises Step c), in this process, be to add to described oil-in-water emulsion Step b)In the inverse latex that forms during end, to obtain described composition from reversible inverse latex form.
10. the method described in claim 8 or 9, it also comprises Step b 1 , in this process, if suitably implementing Step c)Before, will available from Step b)Inverse latex concentrate to obtain the described composition of spissated inverse latex form.
11. the method described in claim 10, it also comprises Step c 1 , in this process, will available from Step c)Concentrate to obtain spissated described composition from reversible inverse latex from reversible inverse latex form.
12. as the method for claim 8 to 11 described in each, it also comprises Step d), in this process, will available from Step b)Inverse latex, available from Step b1)Concentrated inverse latex, available from Step c)From reversible inverse latex or available from Step c1)Concentrate from reversible inverse latex spraying drying, to form the electrolytical powder of described anionoid polymerization.
13. as the composition of claim 1 to 7 described in each or the purposes of the powder described in claim 13, as thickening material and/or the emulsifying agent in makeup or the pharmaceutical composition.
14. makeup or pharmaceutical composition, it is characterized in that its contain significant quantity as the composition of claim 1 to 7 described in each or as powder by the acquisition of the method as claim 12 described in as emulsifying agent and/or thickening material.
CN201180057532.3A 2010-11-30 2011-11-16 Without the novel polymeric thickening material of acrylamide fragment, its preparation method and the composition containing this polymeric viscosifier Expired - Fee Related CN103228725B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1059944 2010-11-30
FR1059944A FR2968007B1 (en) 2010-11-30 2010-11-30 NOVEL POLYMERIC THICKENER FREE FROM ANY ACRYLAMIDO FRAGMENT, PROCESS FOR THEIR PREPARATION AND COMPOSITION CONTAINING THE SAME.
PCT/FR2011/052648 WO2012072911A1 (en) 2010-11-30 2011-11-16 Novel polymeric thickening agent free of acrylamide fragments, method for the preparation thereof, and composition containing same

Publications (2)

Publication Number Publication Date
CN103228725A true CN103228725A (en) 2013-07-31
CN103228725B CN103228725B (en) 2016-04-06

Family

ID=43735157

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201180057532.3A Expired - Fee Related CN103228725B (en) 2010-11-30 2011-11-16 Without the novel polymeric thickening material of acrylamide fragment, its preparation method and the composition containing this polymeric viscosifier

Country Status (7)

Country Link
US (1) US9144610B2 (en)
EP (1) EP2646510B1 (en)
JP (1) JP5917550B2 (en)
KR (1) KR20130141558A (en)
CN (1) CN103228725B (en)
FR (1) FR2968007B1 (en)
WO (1) WO2012072911A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115003750A (en) * 2019-12-09 2022-09-02 化工产品开发公司Seppic Inverse latex for cosmetic compositions combining a specific sequestering agent and a polyelectrolyte with weak acid functions

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10773973B2 (en) * 2013-03-08 2020-09-15 Ecolab Usa Inc. Enhanced foam removal of total suspended solids and multiply charged cations from aqueous or aqueous/oil mixed phase via increased viscoelasticity
US10435308B2 (en) 2013-03-08 2019-10-08 Ecolab Usa Inc. Enhanced foam fractionation of oil phase from aqueous/oil mixed phase via increased viscoelasticity
FR3104166B1 (en) * 2019-12-09 2021-12-10 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic Detergent composition comprising an inverse latex combining a particular sequestering agent and a polyelectrolyte comprising a weak acid function
WO2022248317A1 (en) 2021-05-26 2022-12-01 Rhodia Operations COMPOSITION FOR PAINTING/COATING APPLICATIONS CONTAINING A PARTICULAR COPOLYMER DISPERSANT WITH AT LEAST ONE β-CARBOXYETHYL ACRYLATE MONOMER
WO2022248591A1 (en) 2021-05-26 2022-12-01 Rhodia Operations Agrochemical composition containing a particular copolymer dispersant with at least one β-carboxyethyl acrylate monomer

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284708A (en) * 1979-03-24 1981-08-18 Agfa-Gevaert Aktiengesellschaft Photographic film unit for the production of colored transfer images
US4359564A (en) * 1980-03-14 1982-11-16 Rohm & Haas Co. Addition polymer of oligomeric polyesters of acrylic acid
US4772659A (en) * 1984-04-04 1988-09-20 Calgon Corporation Surfactant system for emulsion polymers
US5185395A (en) * 1991-03-27 1993-02-09 Exxon Chemical Patents Inc. AMPS copolymer emulsions with improved stability
CN1871261A (en) * 2003-10-22 2006-11-29 化工产品开发公司Seppic Novel concentrated inverse latex, production method and use thereof in industry

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2847481A1 (en) 1978-11-02 1980-05-14 Bayer Ag METHOD FOR THE PRODUCTION OF HARDENABLE ORGANOSILOXANE MATERIALS TO BE ELASTOMERALLY WITH REDUCED COMPRESSION RESISTANCE
FR2668080B1 (en) 1990-10-17 1993-08-13 Seppic Sa SELF-EMULSIONABLE COMPOSITIONS BASED ON FATTY ALCOHOLS, THEIR PREPARATION PROCESS AND THEIR USE FOR MAKING EMULSIONS.
FR2712595B1 (en) 1993-11-19 1995-12-22 Seppic Sa A concentrate comprising alkyl glycosides and its uses.
FR2762317B1 (en) 1997-04-21 1999-07-09 Seppic Sa COMPOSITION BASED ON ALKYLPOLYGLYCOSIDES AND FATTY ALCOHOLS AND USES THEREOF
FR2786493B1 (en) * 1998-11-27 2003-08-01 Seppic Sa PROCESS FOR THE PREPARATION OF A THICKENING LATEX WITHOUT ALKANOLAMIDE, USE OF SAID LATEX IN COSMETOLOGY AND COMPOSITION CONTAINING THE SAME
EP1010708B1 (en) * 1998-12-18 2004-03-31 Societe D'exploitation De Produits Pour Les Industries Chimiques, S.E.P.P.I.C. Use in cosmetics of an inverse latex stable against electrolytes
FR2856691B1 (en) * 2003-06-26 2005-08-26 Seppic Sa NOVEL POWDER POLYMER, PROCESS FOR PREPARING THE SAME, AND USE AS THICKENING
DE102009014877A1 (en) 2009-03-25 2009-09-24 Clariant International Ltd. New polymer comprising nitrogen containing-, carbonyl containing-, and crosslinking structural units useful e.g. as thickener and emulsifier, and cosmetic, dermatological or pharmaceutical composition

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284708A (en) * 1979-03-24 1981-08-18 Agfa-Gevaert Aktiengesellschaft Photographic film unit for the production of colored transfer images
US4359564A (en) * 1980-03-14 1982-11-16 Rohm & Haas Co. Addition polymer of oligomeric polyesters of acrylic acid
US4772659A (en) * 1984-04-04 1988-09-20 Calgon Corporation Surfactant system for emulsion polymers
US5185395A (en) * 1991-03-27 1993-02-09 Exxon Chemical Patents Inc. AMPS copolymer emulsions with improved stability
CN1871261A (en) * 2003-10-22 2006-11-29 化工产品开发公司Seppic Novel concentrated inverse latex, production method and use thereof in industry

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115003750A (en) * 2019-12-09 2022-09-02 化工产品开发公司Seppic Inverse latex for cosmetic compositions combining a specific sequestering agent and a polyelectrolyte with weak acid functions

Also Published As

Publication number Publication date
FR2968007B1 (en) 2014-03-14
EP2646510A1 (en) 2013-10-09
JP2013545851A (en) 2013-12-26
KR20130141558A (en) 2013-12-26
US20130190410A1 (en) 2013-07-25
CN103228725B (en) 2016-04-06
JP5917550B2 (en) 2016-05-18
WO2012072911A1 (en) 2012-06-07
US9144610B2 (en) 2015-09-29
EP2646510B1 (en) 2015-03-04
FR2968007A1 (en) 2012-06-01

Similar Documents

Publication Publication Date Title
JP5323954B2 (en) NOVEL POWDER POLYMER, METHOD FOR PREPARING THE SAME, AND METHOD OF USE AS A THINKING AGENT
CN1869080B (en) Inverse latices of copolymers of amps and of N,N-dimethylacrylamide, cosmetic use
KR101239147B1 (en) Liquid Dispersion Polymer Compositions, their preparation and their use
CN1871261B (en) Novel concentrated inverse latex, production method and use thereof in industry
AU770521B2 (en) Liquid dispersion polymer compositions, their preparation and their use
US6375959B1 (en) Thickening homopolymer, preparation process and cosmetic applications
JP5426013B2 (en) A new thickening polymer for powder foam.
KR100884223B1 (en) Liquid dispersion polymer compositions, their preparation and their use
CN102548532A (en) Novel powdered polymer, preparation method thereof and use of same as a thickener
CN103228257B (en) The new electrolyte-resistant cationic thickener that can use through wide pH scope, its preparation method and the compositions containing it
CN103228725B (en) Without the novel polymeric thickening material of acrylamide fragment, its preparation method and the composition containing this polymeric viscosifier
US20010053801A1 (en) Inverse latexes based on white mineral oil, squalene or hydrogenated polyisobutene, cosmetic, dermocosmetic, dermopharmaceutical or pharmaceutical compositions containing them
CN102076324A (en) Novel inverse latices that are free of oxyethylene derivatives, and cosmetic, dermocosmetic, dermopharmaceutical or pharmaceutical compositions comprising same
JP4763229B2 (en) Self-reversible reversed-phase microlatex composition and cosmetics
JP5727001B2 (en) Novel self-reversing inverse latex and its use as a thickener in cosmetic compositions
CN103228258B (en) Novel cationic thickeners usable over a wide pH range, method for the preparation thereof, and composition containing same
KR20140009213A (en) Novel cationic thickeners usable over a wide ph range, method for the preparation thereof, and composition containing same

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20160406

Termination date: 20191116